INTRODUCTION
Death in patients hospitalized with acute myocardial infarction is mainly due to the mechanical failure of the myocardium (1) . Such cardiac failure is more likely the result of large noncontractile zones consequent to large myocardial infarction (2, 3) . Accordingly, several investigations have been carried out in an attempt to limit the extent ofthe damage to the myocardium after a coronary occlusion, while this injury is still in the reversible phase, consequently limiting the size of the established myocardial infarction (4) . In these experimental studies, myocardial damage was reduced with agents aimed at decreasing myocardial oxygen consumption (5) (6) (7) (8) (9) , at increasing coronary flow either directly by reperfusion (10, 11) or indirectly by enhancing collateral flow (5, 6, 12) , by enhancinig anaerobic metabolism (13) , and by the administration of hyaluronidase (14) and hydrocortisone (15) . The application ofthese principles to the therapy of patients with acute myocardial infarction using some of these interventions seems to confirm these experimenital conclusions (4, 6, (16) (17) (18) (19) (20) (21) .
Recent advances in the understaniding of the role that is played by the compleimient systemn in nonspecific injury of the organism (22) (23) (24) (25) and the possibility that the complement system may also plaxy a role in ThleJouirnal of Clinical Investigation Voluime 61 Marchi 1978 661-6706 661 production of myocardial injury caused by anoxia (26) stimulated this investigation of the effect of inhibiting the activity of C3 with cobra venom factor (24-28) on infarct size after acute experimental coronary artery oceclusion.
METHODS
Atnimal preparation anid protocols. Studies were carried out in 28 mongrel dogs anesthetized with intravenous sodium thiamylal (25 mg/kg). Respirationi was mainitained by a Harvard respirator (Harvard Apparatus Co., Inc., Millis, Mass.). The heart was exposed through a left thoracotomy and suspended in a pericardial cradle. The left ainterior descenldinig coronary artery or its apical branich was dissected free from the adjacent tissue and, when desired, occluded with a ligature. The left arterior desceniding coronary artery was not oceluded at a certain distanice from its origin, because this procedure, due to the anatomic variability of coronary distribution does not result in infarctions of comparable size. As previously described (5, 14) , epicardial electrogramiis were obtained from 10 to 15 sites on the anterior surface of the left ventricle distributed in the area supplied by the occluded artery as well as areas remote from it, presumably adequately perfused. Each site selected for electrocardiographic recordinig was recognized by its specific relationship to the branching of the coronary arteries and veins. Sites were chosen from withlin the area supplied by the occluded vessel, from distant regions (and, therefore, presumably normiial), and from the border zone. Inasmuch as the distributioni ofthe branches of coronary arteries is different in each animal, sites for electrocardiographic recordings were located arbitrarily in each dog. The input impedance of the recorder amplifier was 100 Mohm, and the frequency response ofthe system was ±0.5 dB from 0.14 to 70 Hz. The impedance of the electrode was milaintained constant, as reflected in the reproducibility ofthe tracings. The electrode employed was a 15 mm2 copper cylinder with a saline-soaked wick connected to the precordial "V" lead and held by a cable perpenidicular to the electrode, thus minimizing mechanical stress. Because of the large area of the electrode, small variations in locationi did not change the configuration of the recordings. The electrogramns obtained with this system are reproducible after subsequent coronary artery occlusion (5) . The site ofocclusioni was selected so that it might result in a moderate-sizedl area of infarctioni (i.e. with a range of 5-25 g) so that, On the one hand, enough myocardium would be available for biopsies and, oIn the other hand, the area would not be so extensive as to resuilt in focal infarction block (i.e., QRS duration over 0.065 s or intrinsicoid deflectioni exceeding 0.040 s [29] ). Electrocardiographic recordings were obtained before occlusioni and 15 mill after.
The chest was then closed in layers and drainied with an underwater catheter. The dogs were then divided alternately into two groups: a control group (14 clogs) in which nio therapy was administered and an experimental group (14 dogs) in which cobra venom factor (CVF)l (20 U/kg) was administered intravenously in a bolus 30 min after ocelusion. Otherwise the two groups were treated identically, and each dog received saline 20 mil/kg per 24 h intraveniously. During this 24-h period, arterial pressure was monitored through a Stathamn P23Db) pressture gauge (Stathamii Instrumenits Div. Goukl Inc., 1 Abbreviations used in this paper: CH50, hemolytic complement activity producing 50% lysis of sensitized erythrocytes; CPK, creatine phosphokinase; CVF, cobra venom fatctor; RMBF, regionial myocardial blood How; SDS, sodiuim dodecyl silf'ate.
Oxnard, Calif), and electrocardiograms (lead aVF) were monitored continuously. 24 h after occlusion the dogs were reanesthetized, reintubated, the chests were reopened and the hearts excised. Specimens were taken from eight sites from which epicardial electrograms had previously been obtained. They were selected to include two specimens from the normal myocardium and six specimens from sites with ST-segment elevations. A specimen could include either one or two electrocardiographic sites with the same ST-segment elevations. These were tranismural biopsies and were divided longitudinally in two, one specimen of 400 mg was analyzed for creatine phosphokiniase (CPK) activity and the other part of the specimeni (-10() mg) was fixed in Bouin's solutionl for histologic examination using hematoxylin and eosin staining.
Venous clotted blood samples for measurement of complement activity were obtained from all dogs before operation, just before CVF administration and then at 1, 2, 4, 6, 8, 12, and 24 h post-CVF injection. In the control dogs, blood samples were obtained at comiiparable periods. Blood samples were also obtained for determinationi of white blood cell and platelet counts, prothrombin time, partial thromboplastin time, and fibrinogeni concentration. In an additional two healthy dogs, the same amount of CVF was injected intravenously, and complement levels observed in the blood for 2 wk, to determine the duration of comiiplenment level depression.
In 10 additional dogs with coronary artery occlusions (five controls and five CVF treated), regional myocardial blood flow was measured 15 min after coronary artery occlusion (i.e. before CVF adminiistration) and again 6 h later, by the radiolabeled microspheres method (30) (31) (32) , to assess whether CVF administration altered the usual pattern of evolution of collateral flow to the ischemic zone after occlusion.
In two control dogs, biopsies were taken from normal and from infarcted tissue 24 h after occlusion and analyzed by immunofluorescent methods. The biopsies were quick frozen, and 4-,um sections were cut and stained with fluoresceinlabeled sheep anti-dog IgG, C3, fibrinogen, and albumin. These antisera were m)onospecific by immunoelectrophoresis.
In four other dogs with a left anterior descending coronary artery occlusioin, a riigid cannula was placed in the left ventricular cavity through the apex, and the effect of the intravenous CVF administration on left ventricular systolic and end diastolic pressure and dP/dt recorded, to assess whether CVF has a direct effect on myocardial functioni.
Mvocardial CPK anialysis was carried out as previously desc-ibed (5) by spectrophotometric assay. CVF itself did not influence the CPK assay system as judged by experiments with purified CPK, myocardial tissue slices, and homogenate with and without added CVF.
Histological studies were carried out on 5-,um thick histologic sections of tissue that had been fixed in Bouin's solution, dehydrated in iniereasinig concentrationis of ethyl alcohol, cleared in toluene, embedded in paraffini, and stained with hematoxylin and eosin. Each specimen was coded, and thus the histologic examinatioin wvas carried ouit by the pathologist without knowledge of the origin of the specimen. The sections were classified as normal or as showing signs of early myocardial necrosis as described in detail previously (13) . The results were then analyzed using the Chi-square test.
In additioni, in each slide the number of neutrophils per five high power fields (x400) were counted in the border area of the infarct which is the usual location of these cells 24 h after coronary occlusion (24-h-old infaretions and their borders can be localized by gross inspection of the heart). Thereafter, the number of neutrophils in the five fields was averaged. The number of neutrophils contained in the area of ST-segment elevationv was then compared between the CVF-treated and uintreated animlals uisinig Sttudent's t test for grouip observa-ti0o11s. 662 NXlaroko et al. (30, 31) . The microspheres, suspenided in a solution of 50% sucrose with two drops of Tween 80 (ICI United States, Inc., Wilmington, Del.) to avoid aggregation, were mechanically agitated and ultrasoniicated for 45 min bef'ore use. 15 min and 6 h after the occlusion, 4 ml containing 1.5 x 106 of one type of labeled microsphere was injected over 15 s through a catheter placed in the left atriumil; during the next 15 s the catheter was flushed with 5 ml saline; simultaneously, a reference sample was collected through a catheter placed in the femoral artery using a 50(-ml heparinized plastic syringe placed in a Harvard withdrawal pUmllp (Harvard Apparatus Co.) operating at a conistant rate of 15.3 ml/min. 6 h after occlusion this procedure was repeated with the other isotope-labeled microspheres. No changes in heart rate or arterial pressure were observed after the injectioni. At the end of the experiment, 6 h after the occlusion, the heart wvas rapidly excised, and eight transmural biopsies (weighing 2.25±0.06 g) were obtained. They contained all the ischemic tissue as well as normal portions from the aniterior and posterior ventricular walls. The biopsies were then divided into endocardial and epicardial layers. The radioactivitv of the reference blood sample and of the tissue specimens was counted in a gamma scintillationi well counter (model 4233
Nuclear-Chicago Corp., Des Plaines, Ill.). Calculations of RMIBF and cardiac output (CO) were made as described by Utley et al. (32) .
Endocardial, epicardial, and transmural RNIBF of the normal and of the ischemic sites were compared separately, considering each site where the flow was <60 ml/min per 100 g, 15 min after occlusion, to be ischemic. The comparison of the flows was made between the values obtained after the control period of 15 min and those collected after 6 h, using the Student's paired t test.
Purification of the CVF. Lyophilized Naija naja venom (Ross Allen's Reptile Institute, Inc., Silver Springs, Fla.) was reconistituted and chromatographed on DEAE-cellulose and Sephadex G-200 (Pharmacia Fine Chemicals Inc., Piscataway, N. J.) according to the method of Ballaw and Cochrane (33) . After dissolving 1 g of venom in 65 ml sodium phosphate buffer, 0.03M, pH 7.4 at 37°C, the sample is applied to a 2.5 x 40-cm column of equilibrated DEAE-cellulose. The nionbound proteins, mostly phospholipase, are washed through at 50 ml/h for [16] [17] [18] h. A linear salt gradient to 0.5 M NaCl is then begun, and the anticomplementary peak is concentrated and applied to a G-200 column in isotonic saline phosphate buffer, pH 7.4. The final peak is a homogenous band on polyacrylamide electrophoresis (34) (Fig. 1) , and when assayed according to the hemolytic complement activity producing 50% lysis of sensitized erythrocytes (CH50) inhibition method of Ballow and Cochrane (33) has a specific activity in the range of 4 ,ug protein/U. A very faint second band, close to the main band, was seen on the sodium dodecyl sulfate (SDS) gel. Because this apparent contaminant disappears upon treatment, it consists of subunits, and may therefore represent a structural variant or breakdown product of the major component. The nature of this additional band, present in all CVF purified by present methods (33), has not been further investigated. In no instance was there any apparent toxic effect of CVF administration in dogs or rats, suggesting that phospholipase or endotoxin contamination, if present at all, was minimal. In purification of CVF, care must be taken to avoid contact with unsiliconized glass, as we have found it to aggregate upon storage in other than plastic or siliconized containers. below the major protein. In the presence of/8-mercaptoethanol (center) the 135,000 dalton molecule is reduced to subunits of 80,000 and 51,000. An additional 34,000 dalton band appears to represent further breakdown into subunits. The faint second band is no longer present after reduction. Bovine serum albumin is shown on the right for reference.
Hemolytic complement activity in the serum. Hemolytic complement activity was measured by calculation from the dilution producing 50% lysis of optimally sensitized sheep erythrocytes by the method of Kent and Fife (35) .
RESULTS
Group I-occlusion alone. The predictive value of ST-segment elevation for CPK activity and histological structure 24 h later was established in this group (14 dogs, 111 specimens). Sites remote from the region dependent upon a blood supply from the occluded artery with normal ST segments 15 min after occlusion (0-2 mV elevation) showed normal CPK activity 24 32 specimens]). The log of the CPK activity 24 h after occlusion was inversely proportional to STsegment elevation 15 min after occlusion: log CPK = -0.060 ST + 1.48 (r = 0.77, n = 111 specimens). Therefore, higher ST-segment elevation 15 min after occlusion was predictive of lower CPK activity 24 Each of the 14 dogs exhibited a similar pattern in the relationship between ST-segment elevation 15 min after occlusion and CPK activity 24 h later. Thus, when this relationship was analyzed in each dog separately, the average slope was 0.072+0.005 (Table I) . 97% (29/30 specimens) of sites with normal STsegment elevation (0-2 mV elevation) showed normal myocardial structure (Fig. 2) . 97% (69/71) of sites with ST-segment elevation exceeding 2 mV 15 min after occlusion exhibited early signs of myocardial infarction. These findings included a more pronounced eosinophilic appearance, loss of myofiber crossstriation, karyolysis, and karyorrhexis ( Figs. 2 and 4 ). The number of polymorphonuclear neutrophils in each slide from a specimen that exhibited ST-segment elevation averaged 27.0±2.2 (SEM). Serum complement levels, as measured by CH50, in 35 normal dogs were 190+48 U (±1 SD). In dogs in the control group CH50 either was unchanged or fell slightly; however, it always remained within normal limits.
Examination of infarcted tissue, including the healthy margins from two control dogs, by immunofluorescent microscopy revealed no deposition of IgG, C3, or albumin. In areas of marked necrosis, focal areas of fibrinogen were seen interspersed between the myofibrils.
In five control dogs RMBF was measured 15 min and 6 h after coronary artery occlusion (Table II ). In the nonischemic sites, the transmural, endocardial, and epicardial flows were 96.6+4.0, 97.3+±4.0, and 98.6+±4.6 ml/min per 100 g and 114.6±6.2, 111.7+5.9, and 115.6±8.3 ml/min per 100 g, respectively. In the ischemic sites, the RMBF fell between 15 Group Il-occlusioni plus CVF. In this group of 14 dogs, the CVF (20 U/kg) was administered 30 min after occlusion, i.e., after completion of epicardial mapping. Sites remote from the occluded area that showed normal ST segments (0-2 ImlV elevation) showed normal CPK activity which was not different from that in the control group, showing that CVF by itself did not change CPK activity (34.0+1.1 as compared to 34.9+0.9 lU/mg of protein). However, CPK activities in many sites that did show ST-segment elevation over 2 mV, and thus were expected to have CPK depression, were within normal limits. In sites in which CPK was depressed this was less marked than in the control group ( Figs. 3 and 5 ). Histologically, several sites with ST-segment elevations exceeding 2 mV, which were expected to show histological signs of early myocardial necrosis, were completely normal ( Figs. 4 and 5) . In all dogs, the reduced depression of CPK activity subsequent to the administration of CVF 30 min after occlusion was reflected in a significantly (P < 0.001) less steep slope: log CPK = -0.024 ST + 1.46 (n = 111, r = 0.060; Fig. 3 ). This relationship was different from that which existed in the control dogs in each of the animals treated with CVF, with an average slope of 0.032+0.003, which is significantly less than in the inidividual control dogs (0.072±0.009, P < 0.001; Table  I ). Histologically, all (29/29) sites with normal (0-2 mV) ST-segment elevation exhibited normal structure, as expected. However, 46% (36/79) of sites that showed ST-segment elevation exceeding 2 mV at 15 min after occlusion and thus before CVF administration, exhibited normal histologic appearance 24 h later, showing preservation of cell integrity as a consequence of CVF administration (X2 = 33.9, P < 0.0005).
The infiltration of polymorphonuclear neutrophils was reduced in the CVF-treated dogs. The average number of neutrophils in sites with ST-segment elevation exceeding 2 mV was 6.8±+ 0.9 which is significantly lower than in the control series ( after CVF administration (Fig. 6 ). It was one initial activity 2 h after the injection and re low levels 4-6 h later, maintaining the mir for the entire 24 h. In fact, in the two additi4 dogs in which the same dose of CVF was inj continued at reduced levels for 5-9 days. In five dogs treated with CVF 30 min afte RMBF determined 15 min after occlusion CVF administration) was similar to that of dogs (Table II) 103.5± 13.3 ml/min per 100 g. The flow in ti zone fell in a manner similar to that in the co Transmural, endocardial, and epicardial 20.1±5.8, 11.6+2.9, and 24.9+8.4 ml/min respectively.
Heart rate, mean arterial pressure, and appearance of multifocal arrhythmias chars this canine model were not different in the two groups (Table III) , showing that changes in the rhythm and heart rate are not indicative of infarct size (13) . Four dogs in the control group and three in the CVF group died in this period as a result ofthese arrhythmias. CVF did not have a direct effect on cardiac output, left ventricular pressures, and left ventricular dP/dt. Cardiac output determined 15 min after occlusion and 6 h later showed that both the CVF-treated and untreated dogs showed a fall of -300 ml/min (Table II) . Left ventricular dPldt recorded before CVF administration and 30 min after showed no significant changes (2,447±176 and 2,382+209 mm HgIs, respectively).
I'/ ,o
Left ventricular systolic and end diastolic pressures 10 24 also did not change (140±3/4+1-139±4/4+1 mm Hg).
Also, there were no differences between the untreated activity CH50 and CVF-treated groups in respect to hematocrit, white ote the sharp blood cell count, platelet count, prothrombin time, iected, CH50 physiological and pathological processes (22) (23) (24) (25) (26) (27) (28) 36) .
Of special interest is the existence of leukotactic r occlusion, (chemotactic) factors derived from C3 and C5, and the (i.e. before enhancement of phagocytosis, changes in capillary the control permeability, and increase of nonspecific injury to cell ,ardial, and membrane (cytolytic activity) mediated also by compozone were nents of the complement system acting in sequence n per 100 g from C3 to C9. Flexner and Noguchi (37) first described espectively, the anticomplementary activity of cobra venom; Klein er 100 g. 6 h and Wellensiek (38) demonstrated that the activities of flows in the C3 and C5 were abrogated by the cobra venom. In 1966 ÷ 14.4, and Nelson (39) showed that the primary effect of CVF was he ischemic on C3. The isolation of CVF from venom and the mode introl group. of action were described in detail by Muller-Eberhard flows were and Fjellstrom (27) . CVF activates components of the i per 100 g, alternative pathway of complement activation, generating C3 activator which specifically cleaves C3. CVF the time of appears to be the C3 of the cobra, and exerts its potent acteristic of effect in mammals because of resistance to the action of C3 inactivator (40) , C3 acts as a triggering stimulus in formation of the alternative pathway C3 conivertase made up of activated factor B and D. The purified factor is free of neurotoxin (phospholipase) and does not affect the clotting system when administered in vivo, although guinea pigs, but not rabbits, may have some reduction in fibrinogen levels (41) . No CVF-induced alterations of dog fibrinogen levels were founid in the present studies. These properties, and CVF effects on other models of complemenit and neutrophil-mediated injury (41) , clearly distinguish this venom derivative from the anticoagulant arvin, a venom product prepared from a different genus of snake (42) . We have investigated the possibility that consequent to an acute coronary artery occlusion the damage to myocardial tissue will be reduced if the amount of C3 available in vivo is reduced. This hypothesis was based on the observation of Hill and Ward (26) regarding the importance of complement in nonspecific injury to tissues in general, and to the ischemic myocardium in particular. They demonstrated that C3-split products which are responsible for chemotaxis exist in the infarcted rat myocardium, that they are generated byz the release of proteolytic enzymes from damaged muscle, and that CVF, by reducing C3 concentration, greatly reduced the chemotactic effect. On histologic examination, they noted reduction in the polymorphonuclear infiltrate, but were unable to assess the effects of CVF in protecting the ischemic myocardium because it was difficult to evaluate decreases in myocardial infarctions withouit a prediction of the extent of myocardial necrosis. We took advantage of a method that can evaluate changes in the size of infarction by alteration in histology and in CPK activity in sites where electrocardiograms were recorded before CVF administration. Also, CPK activity is completely independent of histological appearance and of leukocyte infiltration because leukocytes do not exhibit CPK activity. Using this techniqlue, in which each myocardial site's fate is predictable by early ST changes, it was shown that over 40% of sites expected to show signs of early myocardial infarction did not show them when CVF was administered 30 min after coronary occlusion. These results were also paralleled by observations that myocardial CPK activity was much less depressed than expected in dogs that received CVF; in fact, many acutely damaged sites had completely normal CPK activity. Therefore, both by histological and enzymatic criteria, the extent of tissue damage at 24 h was limited by the administration of CVF.
The observation that CVF administration caused a rather abrupt fall in complement levels within 2 h and that these levels were <20% of normal after [4] [5] [6] h shows that the depression of complement level was accomplished within the time frame in which the damage is still in a reversible phase (4, 6, 10, 11, 15, 32, 43) . The effects of a single dose of CVF, representing =1 mg of protein, decreased complement levels in normal dogs for more than 5 days; however, it is not known whether the tissue would become necrotic when recovery of the complement system occurs after 5 days. Studies with reperfuision of coronary arteries 3 h after occlu-sion have shown that a similar amounit of tissue was spared from undergoing necrosis when analyzed at either 24 h or at 7 days (10, 11), suggesting that sparinig of tissue at 24 h can be representative of chainges at 1 wk after occlusion. However, the possibility that CVF administration induces a delay but not a reduction in myocardial necrosis cannot be ruled out.
The precise mechanism of action of CVF in this study is unknown. Standard fluorescent antibody techni(ues showed that C3 was not normally deposited in iinfarcte(d tissue; however, in the absence of antigen-antibody comiiplexes or C3 receptors on the tissues, complemenit "fixation" would not be expected. Fluid-phase activation, on the other hand, could still result in generationis of complement-split products that play an importanit role in inflammation. In particular, activation of C3 produces a chemotactic factor for polymorphonuclear leukocytes, and further activation of the complenment sequence produces the C5 chemotactic factor. CVF is known to activate C3 via alternative pathway components, resulting in depletion of C3 and C5 in vivo (40), while sparing Cl and C4 (38) . In this way, further generation of chemotactic factors is markedly reduced, because of depletion of the natural substrates from which they are produced. Indeed, in this study there was markedly less polymorphonuiclear infiltration in the CVF-treated dogs than in the dogs with conitrol occlusions, which is in accord with previous observations in the rat (24) . If myocardial injury in the dog releases proteolytic enzymes that activate C3 (23), one would expect that systemic depletion of C3 by CVF would prevent generation of chemotactic or vascular permeability factors in the areas of injury.
Another nonimmunological means by which the complement system may be activated in myocardial infarction is via Cl fixation to mitochondrial membranes, a mechanism known to activate the classic complement pathway, at least as far as C3 (44) . These in vitro findings were in part supported by observations of transient depressions in serum Cl, C4, and C3 functional activities in six patients undergoing myocardial infarction (44) . The CH50 was insensitive to these chaniges, as in our dogs. Regardless of the mechanism for C3 activation, the question of biological importance in our model is whether vascular permeability factors (such as C3a, anaphylatoxin) or chemotactic factors play 668 Maroko et al.
an inflammlatory, and deleterious, role in the marginal regions of infarcted mvocardium. The simplest hypothesis is that reductioni in infarct size and polymorphontuclear infiltration are related phenomena and are secondarv to a reduction in chemotaxis, as shown by Hill and WVard (26) . It is, of course, possible that some unknowni property of CVF is protective, and that cellular infiltratioin is reduced because tissue damage is less. This hypothesis would also require invocation of noinconmplement-dependent chemotactic factors, btit suc h do exist. The trace contaminant, representing 15-20( mg protein per dog, is a candidate for such an unknown factor. Other mechanisms through which the CVF preparationi may influence myocardial damage were explored. Thus, CVF did not alter heart rate, preload (end diastolic pressure), afterload (systolic pressure), or contractility (dPldt), excluding the possibilitv of an effect through alteration in myocardial oxygen re(quirements. On the other hand, CVF did not chainge collateral blood flow to the ischemic myocardiumi, suggesting that this essential mechanism of alterations of the damaged zone is not effective in this case. Because the measured clotting parameters did not show modifications after CVF, it also was considered that importanit effects on the hemostatic system would be unlikely.
In conclusion, the administration of CVF 30 min after coronlary artery occlusion decreased the size of infarction as noted histologically and decreased the amount of necrosis as evaluated by myocardial CPK activity. Considering the known specific mode of action of CVF, it is postulated that these results, based on C3 depletion, are a consequence of a decreased generation of leukotactic factors, thus reducing injury which may be produced by the released lysosomal enzymes from polymorphonuclear leukocytes. Other complementderived activities, such as those affecting vascular permeability, could also play a role. These results illustrate the important role that complement componeints can play in the generation of an inflammatory response, even when activated "nonspecifically," that is, not by an antigen-antibody interaction.
The extrapolationi of these results to the clinical setting must be with extreme caution because the canine model does not mimic fully the clinical conditions. There are also species differences in the distribution of the coronary arteries. Furthermore, it is conceivable that species differences in myocardial response to complement activity and its inhibition could exist, anid it is not known whether infarcts modified in this wav will heal normally. Nevertheless, this nmanner of limiting infarct size differs from those previously suggested (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) because the latter are attempts to reduce it by physiologic or pharmacological miieans, whereas CVF acts by chaniging the reaction of the organism to a nonspecific injury, thus offering a new approach to the reduction of myocardial necrosis after acute coronary occlusion.
